Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis. (Q35187151)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Anthony J Hayes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Joanna Boros-Majewska

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Natalia Salewska

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Edward Borowski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Sladjana Malic

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Xiao-Qing Wei

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Melanie J Wilson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

David W Williams

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

13 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

Medical Microbiology and Immunology

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

341-355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24924305%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Oral cancer prevention and control--the approach of the World Health Organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Increased expression of virulence attributes in oral Candida albicans isolates from human immunodeficiency virus-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Diabetes mellitus as a contributory factor in oral candidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Interactions of Candida albicans with epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Candida albicans pathogenicity mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Oral mucosal fungal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Pathogenesis and treatment of oral candidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Oral candidal infections and antimycotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Current concepts in antifungal pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Polyene macrolide antibiotics and their applications in human therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Amphotericin B and its new derivatives - mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Synthesis and biological evaluation of amphotericin B derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Synthesis and in vitro biological properties of novel cationic derivatives of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Candida albicans, a major human fungal pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

The reproductive and developmental toxicity of the antifungal drug Nyotran (liposomal nystatin) in rats and rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Nystatin-intralipid preparation: characterization and in vitro activity against yeasts and molds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Mechanism of activity and toxicity of Nystatin-Intralipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Improved antifungal polyene macrolides via engineering of the nystatin biosynthetic genes in Streptomyces noursei

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Chemical diversity of polyene macrolides produced by Streptomyces noursei ATCC 11455 and recombinant strain ERD44 with genetically altered polyketide synthase NysC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Biosynthetic engineering of polyene macrolides towards generation of improved antifungal and antiparasitic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

MFAME, N-methyl-N-D-fructosyl amphotericin B methyl ester, a new amphotericin B derivative of low toxicity: relationship between self-association and effects on red blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Tissue-engineered oral mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Three-dimensionally engineered biomimetic tissue models for in vitro drug evaluation: delivery, efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Novel approaches in the rational design of antifungal agents of low toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Studies of the effects of antifungal cationic derivatives of amphotericin B on human erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Host-pathogen interactions and virulence-associated genes during Candida albicans oral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Life, death, and in-between: meanings and methods in microbiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Biofilm lifestyle of Candida: a mini review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Candida biofilms and oral candidosis: treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Characterization of Candida albicans infection of an in vitro oral epithelial model using confocal laser scanning microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Candida albicans dimorphism as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Antifungal resistance of candidal biofilms formed on denture acrylic in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

In vitro method to study antifungal perfusion in Candida biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

In vitro susceptibility of oral Candida to seven antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0343-4

Optimizing efficacy of Amphotericin B through nanomodification.

21 January 2018

1 reference

12 December 2020

Voriconazole and multidrug resistance in Candida albicans

1 reference

12 December 2020

Oral candidosis in patients with advanced cancer

1 reference

12 December 2020

Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity

1 reference

12 December 2020

Quantitative structure-activity relationships in amphotericin B derivatives

1 reference

12 December 2020

Nystatin LF (Aronex/Abbott).

1 reference

12 December 2020

Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in mice

1 reference

12 December 2020

Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis

1 reference

12 December 2020

Significant Improvement of Antifungal Activity of Polyene Macrolides by Bisalkylation of the Mycosamine

1 reference

12 December 2020

Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents.

1 reference

12 December 2020

A novel injectable water-soluble amphotericin B-arabinogalactan conjugate

1 reference

12 December 2020